Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-038076

CEO and Chairman sold 69,680 shares at an average $44.57 ($3,105,912)

  • CEO and Chairman acquired 69,680 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-06-17 Option exercise +28,440 $0.33 $9,385 1,806,620 D
ROBINS CHAD M CEO and Chairman 2020-06-17 Sale −400 $43.76 $17,504 1,806,220 D
ROBINS CHAD M CEO and Chairman 2020-06-17 Sale −28,040 $44.38 $1,244,415 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-06-18 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-06-18 Sale −16,680 $44.41 $740,759 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-06-19 Option exercise +24,560 $0.33 $8,105 1,802,740 D
ROBINS CHAD M CEO and Chairman 2020-06-19 Sale −24,160 $44.91 $1,085,026 1,778,580 D
ROBINS CHAD M CEO and Chairman 2020-06-19 Sale −400 $45.52 $18,208 1,778,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2020-06-17 Option exercise · Stock Option (Right to Buy) −28,440 423,120 D
ROBINS CHAD M CEO and Chairman 2020-06-18 Option exercise · Stock Option (Right to Buy) −16,680 406,440 D
ROBINS CHAD M CEO and Chairman 2020-06-19 Option exercise · Stock Option (Right to Buy) −24,560 381,880 D
Open-market sales · 69,680 sh · avg $44.57 · $3,105,912
Loading xslF345X03/doc4.xml…